128 related articles for article (PubMed ID: 9366419)
1. HLA-DP2: self peptide sequences and binding properties.
Chicz RM; Graziano DF; Trucco M; Strominger JL; Gorga JC
J Immunol; 1997 Nov; 159(10):4935-42. PubMed ID: 9366419
[TBL] [Abstract][Full Text] [Related]
2. The HLA-DP2 protein binds the immunodominant epitope from myelin basic protein, MBP85-99, with high affinity.
Hansen BE; Nielsen CH; Madsen HO; Ryder LP; Jakobsen BK; Svejgaard A
Tissue Antigens; 2011 Mar; 77(3):229-34. PubMed ID: 21299528
[TBL] [Abstract][Full Text] [Related]
3. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL
Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674
[TBL] [Abstract][Full Text] [Related]
4. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles.
Kirschmann DA; Duffin KL; Smith CE; Welply JK; Howard SC; Schwartz BD; Woulfe SL
J Immunol; 1995 Dec; 155(12):5655-62. PubMed ID: 7499850
[TBL] [Abstract][Full Text] [Related]
5. Naturally processed cytokine-derived peptide bound to HLA-class II molecules.
Harris PE; Maffei A; Liu Z; Colovai I; Reed EF; Inghirami G; Suciu-Foca N
J Immunol; 1993 Dec; 151(11):5975-83. PubMed ID: 8245442
[TBL] [Abstract][Full Text] [Related]
6. Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8.
Chicz RM; Lane WS; Robinson RA; Trucco M; Strominger JL; Gorga JC
Int Immunol; 1994 Nov; 6(11):1639-49. PubMed ID: 7865457
[TBL] [Abstract][Full Text] [Related]
7. Conformational and structural characteristics of peptides binding to HLA-DR molecules.
Hill CM; Hayball JD; Allison AA; Rothbard JB
J Immunol; 1991 Jul; 147(1):189-97. PubMed ID: 1711073
[TBL] [Abstract][Full Text] [Related]
8. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase.
Kwok WW; Domeier ML; Raymond FC; Byers P; Nepom GT
J Immunol; 1996 Mar; 156(6):2171-7. PubMed ID: 8690906
[TBL] [Abstract][Full Text] [Related]
9. Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by pool sequencing.
Verreck FA; van de Poel A; Termijtelen A; Amons R; Drijfhout JW; Koning F
Eur J Immunol; 1994 Feb; 24(2):375-9. PubMed ID: 8299686
[TBL] [Abstract][Full Text] [Related]
10. Characterization of T cell epitopes restricted by HLA-DP9 in streptococcal M12 protein.
Dong RP; Kamikawaji N; Toida N; Fujita Y; Kimura A; Sasazuki T
J Immunol; 1995 May; 154(9):4536-45. PubMed ID: 7536773
[TBL] [Abstract][Full Text] [Related]
11. Characterization of natural peptide ligands from HLA-DP2: new insights into HLA-DP peptide-binding motifs.
Díaz G; Cañas B; Vazquez J; Nombela C; Arroyo J
Immunogenetics; 2005 Jan; 56(10):754-9. PubMed ID: 15565337
[TBL] [Abstract][Full Text] [Related]
12. Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming.
Kropshofer H; Max H; Halder T; Kalbus M; Muller CA; Kalbacher H
J Immunol; 1993 Nov; 151(9):4732-42. PubMed ID: 8409432
[TBL] [Abstract][Full Text] [Related]
13. Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.
Reed AM; Collins EJ; Shock LP; Klapper DG; Frelinger JA
J Immunol; 1997 Dec; 159(12):6260-5. PubMed ID: 9550430
[TBL] [Abstract][Full Text] [Related]
14. Definition of specific peptide motifs for four major HLA-A alleles.
Kubo RT; Sette A; Grey HM; Appella E; Sakaguchi K; Zhu NZ; Arnott D; Sherman N; Shabanowitz J; Michel H
J Immunol; 1994 Apr; 152(8):3913-24. PubMed ID: 8144960
[TBL] [Abstract][Full Text] [Related]
15. Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8.
DiBrino M; Parker KC; Shiloach J; Turner RV; Tsuchida T; Garfield M; Biddison WE; Coligan JE
J Immunol; 1994 Jan; 152(2):620-31. PubMed ID: 7506728
[TBL] [Abstract][Full Text] [Related]
16. Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires.
Raddrizzani L; Sturniolo T; Guenot J; Bono E; Gallazzi F; Nagy ZA; Sinigaglia F; Hammer J
J Immunol; 1997 Jul; 159(2):703-11. PubMed ID: 9218585
[TBL] [Abstract][Full Text] [Related]
17. Determination of the peptide binding motif and high-affinity ligands for HLA-DQ4 using synthetic peptide libraries.
Volz T; Schwarz G; Fleckenstein B; Schepp CP; Haug M; Roth J; Wiesmüller KH; Dannecker GE
Hum Immunol; 2004 Jun; 65(6):594-601. PubMed ID: 15219379
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs.
Geluk A; van Meijgaarden KE; Southwood S; Oseroff C; Drijfhout JW; de Vries RR; Ottenhoff TH; Sette A
J Immunol; 1994 Jun; 152(12):5742-8. PubMed ID: 8207204
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity.
Barber LD; Percival L; Arnett KL; Gumperz JE; Chen L; Parham P
J Immunol; 1997 Feb; 158(4):1660-9. PubMed ID: 9029102
[TBL] [Abstract][Full Text] [Related]
20. HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity.
Castelli FA; Buhot C; Sanson A; Zarour H; Pouvelle-Moratille S; Nonn C; Gahery-Ségard H; Guillet JG; Ménez A; Georges B; Maillère B
J Immunol; 2002 Dec; 169(12):6928-34. PubMed ID: 12471126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
